You just read:

Long-Term Safety, Reduction in Disease Activity/Flares and Sustained Efficacy are Among the Key Unmet Needs for New Systemic Lupus Erythematosus (SLE) Treatments

News provided by

BioTrends Research Group

Apr 25, 2013, 09:00 ET